#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Glomerulonephritis acute Immune thrombocytopenia Hereditary neuropathic amyloidosis Glomerulonephritis minimal lesion Adenocarcinoma gastric Synovial sarcoma metastatic Acquired ATTR amyloidosis Hepatitis B B-cell type acute leukaemia Cognitive disorder Synovial sarcoma Neuroendocrine carcinoma metastatic Central nervous system neoplasm Arteriovenous malformation More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Life with Disease Mucopolysaccharidosis III – Diagnostics Haemophilia – Diagnostics Immunodeficiency congenital – Treatment KBG syndrome – Treatment Familial amyotrophic lateral sclerosis – Basic Information Primary mediastinal large B-cell lymphoma Angiosarcoma non-metastatic – Trials in Disease Ewing’s sarcoma recurrent – Diagnostics Synovial sarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexchlorpheniramine Maleate Human Serum Albumin Acetylcholine Chloride Efgartigimod Alfa Siltuximab Tretinoin Atorvastatin Cart45Ra-Nkg2D Cells Nebivolol Hydrochloride Buclizine Hydrochloride Co-Trimoxazole Piritramide Valiltramiprosate Tamibarotene Etelcalcetide Eplontersen Bezafibrate Pf-07220060 Monohydrate Colchicine Masitinib More therapies…

    Learn about Your Condition

    Thyroidectomy Hypotransferrinaemia Malignant fibrous histiocytoma Staphylococcal bacteraemia Influenza Ectopic pregnancy Leiomyosarcoma Chronic disease Bipolar disorder Radius fracture Urea cycle disorder Porphyria non-acute Uterine leiomyoma Diarrhoea Infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Amivantamab and Drug Combination for Patients with Recurrent or Metastatic Colorectal Cancer Without KRAS/NRAS and BRAF Mutations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Amivantamab
    • Bevacizumab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +4

  • Study on the Effect of Carvedilol for Patients with Cirrhotic Portal Hypertension

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Carvedilol
    France

  • Study on Meropenem Dosing for Patients with Serious Infections in Intensive Care

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Linezolid
    Norway

  • Study on Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa Using Skin Grafts with Genetically Corrected Autologous Keratinocytes and Fibroblasts

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epidermolysis bullosa
    Investigated Drugs:
    • AUTOLOGOUS KERATINOCYTES AND FIBROBLASTS TRANSDUCED WITH A RETROVIRAL VECTOR ENCODING COL7A1 CDNA
    France

  • Study on Indapamide for Patients with Chronic Post-Surgical Hypoparathyroidism

    Recruiting

    3 1 1
    Investigated Drugs:
    • INDAPAMIDE HEMIHYDRATE
    Denmark

  • Study on Daridorexant’s Effect on Cognitive Performance in Patients with Chronic Insomnia Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Daridorexant
    Italy
Previous Page
1 … 241 242 243 244 245 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!